Common Stock, Shares, Issued of ARROWHEAD PHARMACEUTICALS, INC. from Q1 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
ARROWHEAD PHARMACEUTICALS, INC. quarterly Common Stock, Shares, Issued history and change rate from Q1 2010 to Q3 2025.
  • ARROWHEAD PHARMACEUTICALS, INC. Common Stock, Shares, Issued for the quarter ending 30 Sep 2025 was 136M shares, a 9.11% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

ARROWHEAD PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 136M +11.3M +9.11% 30 Sep 2025 10-K 25 Nov 2025
Q2 2025 138M +13.9M +11.2% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 138M +13.9M +11.2% 31 Mar 2025 10-Q 12 May 2025
Q4 2024 126M +18.1M +16.8% 31 Dec 2024 10-Q 10 Feb 2025
Q3 2024 124M +17.1M +15.9% 30 Sep 2024 10-K 25 Nov 2025
Q2 2024 124M +17.1M +16% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 124M +17.3M +16.2% 31 Mar 2024 10-Q 09 May 2024
Q4 2023 108M +1.36M +1.28% 31 Dec 2023 10-Q 06 Feb 2024
Q3 2023 107M +1.35M +1.28% 30 Sep 2023 10-K 26 Nov 2024
Q2 2023 107M +1.31M +1.24% 30 Jun 2023 10-Q 07 Aug 2023
Q1 2023 107M +1.17M +1.1% 31 Mar 2023 10-Q 02 May 2023
Q4 2022 106M +1.34M +1.28% 31 Dec 2022 10-Q 06 Feb 2023
Q3 2022 106M +1.63M +1.57% 30 Sep 2022 10-K 29 Nov 2023
Q2 2022 106M +1.59M +1.52% 30 Jun 2022 10-Q 04 Aug 2022
Q1 2022 106M +1.68M +1.62% 31 Mar 2022 10-Q 10 May 2022
Q4 2021 105M +1.6M +1.55% 31 Dec 2021 10-Q 02 Feb 2022
Q3 2021 104M +1.95M +1.91% 30 Sep 2021 10-K 28 Nov 2022
Q2 2021 104M +1.96M +1.92% 30 Jun 2021 10-Q 05 Aug 2021
Q1 2021 104M +2.27M +2.23% 31 Mar 2021 10-Q 04 May 2021
Q4 2020 103M +2.08M +2.06% 31 Dec 2020 10-Q 04 Feb 2021
Q3 2020 102M +6.87M +7.19% 30 Sep 2020 10-K 22 Nov 2021
Q2 2020 102M +7.04M +7.4% 30 Jun 2020 10-Q 05 Aug 2020
Q1 2020 102M +7.08M +7.48% 31 Mar 2020 10-Q 07 May 2020
Q4 2019 101M +8.52M +9.2% 31 Dec 2019 10-Q 05 Feb 2020
Q3 2019 95.5M +7M +7.91% 30 Sep 2019 10-K 23 Nov 2020
Q2 2019 95.2M +7.35M +8.37% 30 Jun 2019 10-Q 05 Aug 2019
Q1 2019 94.7M +7.1M +8.1% 31 Mar 2019 10-Q 08 May 2019
Q4 2018 92.6M +17.7M +23.6% 31 Dec 2018 10-Q 07 Feb 2019
Q3 2018 88.5M +13.7M +18.3% 30 Sep 2018 10-K 25 Nov 2019
Q2 2018 87.9M +13.1M +17.5% 30 Jun 2018 10-Q 07 Aug 2018
Q1 2018 87.6M +12.8M +17.1% 31 Mar 2018 10-Q 08 May 2018
Q4 2017 74.9M +505K +0.68% 31 Dec 2017 10-Q 09 Feb 2018
Q3 2017 74.8M +5.04M +7.23% 30 Sep 2017 10-K 11 Dec 2018
Q2 2017 74.8M +14.3M +23.7% 30 Jun 2017 10-Q 03 Aug 2017
Q1 2017 74.8M +14.8M +24.7% 31 Mar 2017 10-Q 03 May 2017
Q4 2016 74.4M +14.8M +24.8% 31 Dec 2016 10-Q 06 Feb 2017
Q3 2016 69.7M +10.2M +17.1% 30 Sep 2016 10-K 12 Dec 2017
Q2 2016 60.4M +931K +1.57% 30 Jun 2016 10-Q 09 Aug 2016
Q1 2016 60M +525K +0.88% 31 Mar 2016 10-Q 10 May 2016
Q4 2015 59.6M +4.91M +8.98% 31 Dec 2015 10-Q 09 Feb 2016
Q3 2015 59.5M +4.89M +8.94% 30 Sep 2015 10-K 14 Dec 2016
Q2 2015 59.5M +6.59M +12.5% 30 Jun 2015 10-Q 04 Aug 2015
Q1 2015 59.4M +7.57M +14.6% 31 Mar 2015 10-Q 11 May 2015
Q4 2014 54.7M +15.7M +40.3% 31 Dec 2014 10-Q 09 Feb 2015
Q3 2014 54.7M +22.2M +68.2% 30 Sep 2014 10-K 14 Dec 2015
Q2 2014 52.9M +21.6M +69% 30 Jun 2014 10-Q 12 Aug 2014
Q1 2014 51.9M +34.8M +204% 31 Mar 2014 10-Q 06 May 2014
Q4 2013 39M +23.4M +149% 31 Dec 2013 10-Q 04 Feb 2014
Q3 2013 32.5M +18.9M +139% 30 Sep 2013 10-K 25 Nov 2014
Q2 2013 31.3M +20M +177% 30 Jun 2013 10-Q 07 Aug 2013
Q1 2013 17M +6.24M +57.7% 31 Mar 2013 10-Q 09 May 2013
Q4 2012 15.6M +5.11M +48.6% 31 Dec 2012 10-Q 13 Feb 2013
Q3 2012 13.6M +4.94M +57.1% 30 Sep 2012 10-K 18 Dec 2013
Q2 2012 11.3M -60.5M -84.3% 30 Jun 2012 10-Q 13 Aug 2012
Q1 2012 10.8M 31 Mar 2012 10-Q 08 May 2012
Q4 2011 10.5M 31 Dec 2011 10-Q 09 Feb 2012
Q3 2011 8.64M +1.47M +20.5% 30 Sep 2011 10-K 28 Dec 2012
Q2 2011 71.8M 30 Jun 2011 10-Q 08 Aug 2011
Q3 2010 7.17M 30 Sep 2010 10-K 20 Dec 2011
Q1 2010 12.9K* 31 Mar 2010 10-Q 06 May 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.